PREDICTING MAJOR BLEEDING IN PATIENTS RECEIVING ANTICOAGULANT THERAPY - A NATIONWIDE OBSERVATIONAL STUDY

被引:0
|
作者
Ingason, Arnar B.
Bjornsson, Einar
Hreinsson, Johann P.
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Tu1376
引用
收藏
页码:S1321 / S1322
页数:2
相关论文
共 50 条
  • [21] Vitamin E Serum Levels and Bleeding Risk in Patients Receiving Oral Anticoagulant Therapy: a Retrospective Cohort Study
    Pastori, Daniele
    Carnevale, Roberto
    Cangemi, Roberto
    Saliola, Mirella
    Nocella, Cristina
    Bartimoccia, Simona
    Vicario, Tommasa
    Farcomeni, Alessio
    Violi, Francesco
    Pignatelli, Pasquale
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2013, 2 (06):
  • [22] The haemostatic profile in critically ill COVID-19 patients receiving therapeutic anticoagulant therapy An observational study
    Tsantes, Argirios E.
    Frantzeskaki, Frantzeska
    Tsantes, Andreas G.
    Rapti, Evdoxia
    Rizos, Michalis
    Kokoris, Styliani, I
    Paramythiotou, Elizabeth
    Katsadiotis, Georgios
    Karali, Vassiliki
    Flevari, Aikaterini
    Chrysanthopoulou, Evangelia
    Maratou, Eirini
    Kyriakou, Elias
    Gialeraki, Argyri
    Bonovas, Stefanos
    Dimopoulos, George
    Tsangaris, Iraklis
    Armaganidis, Apostolos
    MEDICINE, 2020, 99 (47) : E23365
  • [23] Gastrointestinal Bleeding in Patients Receiving Antiplatelet and Anticoagulant Therapy: Practical Guidance for Restarting Therapy and Avoiding Recurrences
    Pipilis, Athanasios
    Makrygiannis, Stamatis
    Chrisanthopoulou, Eleni
    Sourlas, Nikolaos
    Kaliambakos, Sotirios
    Ntailianas, Apostolos
    HELLENIC JOURNAL OF CARDIOLOGY, 2014, 55 (06) : 499 - 509
  • [24] Hemorrhage in patients with polycythemia vera receiving aspirin with an anticoagulant: a prospective, observational study
    Zwicker, Jeffrey, I
    Paranagama, Dilan
    Lessen, David S.
    Colucci, Philomena M.
    Grunwald, Michael R.
    HAEMATOLOGICA, 2022, 107 (05) : 1106 - 1110
  • [25] Time Course and Subsequent Outcomes of Major Bleeding Events According to Bleeding Site in Patients Receiving Anticoagulant Therapy for Venous Thromboembolism: Insights from the RIETE Registry
    Bikdeli, Behnood
    Nieto, Jose Antonio
    Moustafa, Fares
    Ruiz-Gimenez, Nuria
    Lorenzo, Alicia
    Schellong, Sebastian
    Soler, Silvia
    Morales, Maria Del Valle
    Bosevski, Marijan
    Gavin, Olga
    Monreal, Manuel
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2019, 39
  • [26] Evaluation of postextraction bleeding incidence to compare patients receiving and not receiving warfarin therapy: a cross-sectional, multicentre, observational study
    Iwabuchi, Hiroshi
    Imai, Yutaka
    Asanami, Soichiro
    Shirakawa, Masayori
    Yamane, Gen-yuki
    Ogiuchi, Hideki
    Kurashina, Kenji
    Miyata, Masaru
    Nakao, Hiroyuki
    Imai, Hirohisa
    BMJ OPEN, 2014, 4 (12):
  • [28] Recurrent venous thromboembolism and major bleeding complications during anticoagulant therapy in cancer patients
    Piccioli, A
    Prandoni, P
    Bernardi, E
    Girolami, B
    Rossi, L
    Bagatella, P
    Sabbion, P
    Girolami, A
    THROMBOSIS RESEARCH, 1998, 91 (03) : S123 - S123
  • [29] The importance of pharmacogenetic factors in the occurence of bleeding complications in patients receiving oral acenocoumarol anticoagulant therapy
    Mark, L
    Marki-Zay, J
    Fazekas, Ö
    Szüle, O
    Kondacs, A
    Katona, A
    Fodor, L
    EUROPEAN HEART JOURNAL, 2003, 24 : 194 - 194
  • [30] Avoidance of bleeding during surgery in patients receiving anticoagulant and/or antiplatelet therapy - Pharmacokinetic and pharmacodynamic considerations
    Harder, S
    Klinkhardt, U
    Alvarez, JM
    CLINICAL PHARMACOKINETICS, 2004, 43 (14) : 963 - 981